Deadline: 14-May-25
Pfizer is inviting applications to increase the ability of healthcare professionals to holistically improve the care of HR+/HER2- or HER2+ (regardless of hormonal status) mBC patients.
Area of Interest
- Potential applicants are encouraged to identify and address the educational needs, barriers, and gaps for healthcare professionals to enhance comprehensive care for mBC patients. This may include:
- Educational programs to increase understanding of drug-drug interactions in the selection of mBC treatment(s).
- Educational programs, tools, and/or resources for considering individualized patients’ needs and patient profiles to support clinical decisions.
- Patients’ needs assessment to tackle unaddressed challenges beyond pharmacological treatment.
Funding Information
- Individual projects requesting up to EUR 20,000.00 will be considered. Maximum project length is 18 months.
Target Audience
- Healthcare professionals focused on breast cancer (oncologists, specialty nurses, pharmacists) and other healthcare professionals involved in the care and treatment of people with mBC.
Eligibility Criteria
- The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; patient advocacy organizations, and other entities with a mission related to healthcare professional education and/or healthcare improvement.
- Multi-center projects or collaborations between Health Care professionals and patient advocacy groups are allowed.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- If the project involves multiple departments within an institution and/or between different institutions /organizations/associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
- The applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead’s grant coordinator).
- The project/program lead must be an employee or contractor of the requesting organization.
- For projects offering continuing education credit, the requesting organization must be accredited. It is not the intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.
- Spain only
- HR+/HER2- or HER2+ (regardless of hormonal status) metastatic Breast Cancer
- Requesting organization must be legally able to receive award funding directly Pfizer International LLC.
For more information, visit Pfizer.
